Bright Outlook for SARS Research Funding

Bright Outlook for SARS Research Funding By Bernard Tulsi A single bright spot in the otherwise dark SARS (severe acute respiratory syndrome) story is the new research opportunities it has created for researchers who study infectious diseases. As SARS episodes wax and wane, its long-term public health significance remains unclear. But its severity is undisputed: As of July 1, the World Health Organization (WHO) reported 8,447 cases, including 811 deaths in 30 countries, plus Hong Kong. Th

Bernard Tulsi
Jul 27, 2003

Bright Outlook for SARS Research Funding

By Bernard Tulsi

A single bright spot in the otherwise dark SARS (severe acute respiratory syndrome) story is the new research opportunities it has created for researchers who study infectious diseases.

As SARS episodes wax and wane, its long-term public health significance remains unclear. But its severity is undisputed: As of July 1, the World Health Organization (WHO) reported 8,447 cases, including 811 deaths in 30 countries, plus Hong Kong.

The National Institutes of Health is funding SARS research through its Small Research Grant programs, for which the next application deadline is Oct. 1; and the Small Business Innovation Research and Small Business Technology Transfer programs, each with an application deadline of Aug. 1 (healthresearch.niaid.nih.gov/dmid/ sarsopps.htm#r03).

The National Institute of Allergy and Infectious Diseases opted to accelerate research on SARS and emerging infectious diseases. NIAID's Division of Microbiology and Infectious Diseases unveiled...

Interested in reading more?

The Scientist ARCHIVED CONTENT

ACCESS MORE THAN 30,000 ARTICLES ACROSS MANY TOPICS AND DISCIPLINES

Become a Member of

Receive full access to more than 35 years of archived stories, digital editions of The Scientist Magazine, and much more!
Already a member?